BCYC FY 2023 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$27M+86.5% YoY

Gross Profit

-$130M-480.1% margin

Operating Income

-$190M-704.1% margin

Net Income

-$181M-669.7% margin

EPS (Diluted)

$-5.08

Cash Flow

Operating Cash Flow

-$61M

Free Cash Flow

-$64M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$595M

Total Liabilities

$224M

Stockholders' Equity

$371M

Cash & Equivalents

$526M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$14M	+86.5%
Gross Profit	-$130M	$14M	-995.5%
Operating Income	-$190M	-$117M	-62.8%
Net Income	-$181M	-$113M	-60.3%